The nucleoprotein of newly emerged H7N9 influenza a virus harbors a unique motif conferring resistance to antiviral human MxA

Journal of Virology

Volumn 89, Issue 4, 2015, Pages 2241-2252

  Riegger, David ^a   Hai, Rong ^b   Dornfeld, Dominik ^a   Mänz, Benjamin ^a   Leyva Grado, Victor ^b   Sánchez Aparicio, Maria T ^b   Albrecht, Randy A ^b   Palese, Peter ^b   Haller, Otto ^a   Schwemmle, Martin ^a   García Sastre, Adolfo ^b   Kochs, Georg ^a   Schmolke, Mirco ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ISOLEUCINE; MYXOVIRUS RESISTANCE PROTEIN A; NUCLEOPROTEIN; PROLINE; TYROSINE; CORE PROTEIN; MX1 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; CRYSTAL STRUCTURE; HUMAN; INFLUENZA VIRUS A H7N9; MOUSE; NONHUMAN; PANDEMIC INFLUENZA; PROTEIN DEPLETION; PROTEIN EXPRESSION; VIROGENESIS; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TITRATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; AVIAN INFLUENZA; BIRD; C57BL MOUSE; CELL LINE; CHINA; DNA SEQUENCE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNE EVASION; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H7N9); MOLECULAR GENETICS; TRANSMISSION; VIROLOGY; ZOONOSIS;

AVES; AVIAN INFLUENZA VIRUS; HUMAN INFLUENZA VIRUS; INFLUENZA A VIRUS; MAMMALIA; MUS;

ANIMALS; BIRDS; CELL LINE; CHINA; HUMANS; IMMUNE EVASION; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYXOVIRUS RESISTANCE PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA; VIRAL CORE PROTEINS; ZOONOSES;

EID: 84921658489     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02406-14     Document Type: Article

References (59)

1. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Zhang Y, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381:1916-1925. http://dx.doi.org/10.1016/S0140-6736(13)60903-4.
2. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368:1888-1897. http://dx.doi.org/10.1056/NEJMoa1304459.
3. Neumann G, Macken CA, Kawaoka Y. 2014. Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. J Virol 88:4877-4896. http://dx.doi.org/10.1128/JVI.00107-14.
4. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. 2013. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill 18:20453. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20453.
5. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, Kong H, Gu C, Li X, Liu J, Wang G, Chen Y, Liu L, Liang L, Li Y, Fan J, Wang J, Li W, Guan L, Li Q, Yang H, Chen P, Jiang L, Guan Y, Xin X, Jiang Y, Tian G, Wang X, Qiao C, Li C, Bu Z, Chen H. 2013. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341:410-414. http://dx.doi.org/10.1126/science.1240532.
6. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-809. http://dx.doi.org/10.1128/CMR.14.4.778-809.2001.
7. Borden EC, Williams BR. 2011. Interferon-stimulated genes and their protein products: what and how? J Interferon Cytokine Res 31:1-4. http://dx.doi.org/10.1089/jir.2010.0129.
8. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, Garcia-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691-695. http://dx.doi.org/10.1038/nature12862.
9. Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C. 1986. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147-158. http://dx.doi.org/10.1016/0092-8674(86)90493-9.
10. Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, Weidmann M, Casanova JL, Haller O, Kochs G. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 81:7776-7785. http://dx.doi.org/10.1128/JVI.00546-06.
11. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4:e1000151. http://dx.doi.org/10.1371/journal.ppat.1000151.
12. Haller O, Kochs G. 2011. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31:79-87. http://dx.doi.org/10.1089/jir.2010.0076.
13. Verhelst J, Hulpiau P, Saelens X. 2013. Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiol Mol Biol Rev 77:551-566. http://dx.doi.org/10.1128/MMBR.00024-13.
14. Grimm D, Staeheli P, Hufbauer M, Koerner I, Martinez-Sobrido L, Solorzano A, Garcia-Sastre A, Haller O, Kochs G. 2007. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci USA 104:6806-6811. http://dx.doi.org/10.1073/pnas.0701849104.
15. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, Haller O, Garcia-Sastre A, Staeheli P. 2007. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81:10818-10821. http://dx.doi.org/10.1128/JVI.01116-07.
16. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. 1988. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 8:4518-4523.
17. Pavlovic J, Haller O, Staeheli P. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol 66:2564-2569.
18. Matzinger SR, Carroll TD, Dutra JC, Ma ZM, Miller CJ. 2013. Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells. J Virol 87:1150-1158. http://dx.doi.org/10.1128/JVI.02271-12.
19. Xiao H, Killip MJ, Staeheli P, Randall RE, Jackson D. 2013. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J Virol 87:13053-13058. http://dx.doi.org/10.1128/JVI.02220-13.
20. Dittmann J, Stertz S, Grimm D, Steel J, Garcia-Sastre A, Haller O, Kochs G. 2008. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol 82:3624-3631. http://dx.doi.org/10.1128/JVI.01753-07.
21. Zimmermann P, Manz B, Haller O, Schwemmle M, Kochs G. 2011. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol 85:8133-8140. http://dx.doi.org/10.1128/JVI.00712-11.
22. Manz B, Dornfeld D, Gotz V, Zell R, Zimmermann P, Haller O, Kochs G, Schwemmle M. 2013. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog 9:e1003279. http://dx.doi.org/10.1371/journal.ppat.1003279.
23. Quinlivan M, Zamarin D, Garcia-Sastre A, Cullinane A, Chambers T, Palese P. 2005. Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79:8431-8439. http://dx.doi.org/10.1128/JVI.79.13.8431-8439.2005.
24. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solorzano A, Garcia-Sastre A, Palese P, Bouvier NM. 2013. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun 4:2854. http://dx.doi.org/10.1038/ncomms3854.
25. Staeheli P, Dreiding P, Haller O, Lindenmann J. 1985. Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice. J Biol Chem 260:1821-1825.
26. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg (Lond) 27:493-497.
27. Schmolke M, Manicassamy B, Pena L, Sutton T, Hai R, Varga ZT, Hale BG, Steel J, Perez DR, Garcia-Sastre A. 2011. Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog 7:e1002186. http://dx.doi.org/10.1371/journal.ppat.1002186.
28. Rolling T, Koerner I, Zimmermann P, Holz K, Haller O, Staeheli P, Kochs G. 2009. Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J Virol 83:6673-6680. http://dx.doi.org/10.1128/JVI.00212-09.
29. Ponten A, Sick C, Weeber M, Haller O, Kochs G. 1997. Dominantnegative mutants of human MxA protein: domains in the carboxyterminal moiety are important for oligomerization and antiviral activity. J Virol 71:2591-2599.
30. Pitossi F, Blank A, Schroder A, Schwarz A, Hussi P, Schwemmle M, Pavlovic J, Staeheli P. 1993. A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol 67:6726-6732.
31. Flohr F, Schneider-Schaulies S, Haller O, Kochs G. 1999. The central interactive region of humanMxAGTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett 463:24-28. http://dx.doi.org/10.1016/S0014-5793(99)01598-7.
32. Koerner I, Matrosovich MN, Haller O, Staeheli P, Kochs G. 2012. Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenzaAvirus. J Gen Virol 93:970-979. http://dx.doi.org/10.1099/vir.0.035782-0.
33. Heaton NS, Leyva-Grado VH, Tan GS, Eggink D, Hai R, Palese P. 2013. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol 87: 8272-8281. http://dx.doi.org/10.1128/JVI.00969-13.
34. Solorzano A, Webby RJ, Lager KM, Janke BH, Garcia-Sastre A, Richt JA. 2005. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79:7535-7543. http://dx.doi.org/10.1128/JVI.79.12.7535-7543.2005.
35. Lutz A, Dyall J, Olivo PD, Pekosz A. 2005. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J Virol Methods 126:13-20. http://dx.doi.org/10.1016/j.jviromet.2005.01.016.
36. Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM. 2010. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol 84:4194-4203. http://dx.doi.org/10.1128/JVI.02742-09.
37. Lu X, Renshaw M, Tumpey TM, Kelly GD, Hu-Primmer J, Katz JM. 2001. Immunity to influenza A H9N2 viruses induced by infection and vaccination. J Virol 75:4896-4901. http://dx.doi.org/10.1128/JVI.75.10.4896-4901.2001.
38. Ng AK, Zhang H, Tan K, Li Z, Liu JH, Chan PK, Li SM, Chan WY, Au SW, Joachimiak A, Walz T, Wang JH, Shaw PC. 2008. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J 22:3638-3647. http://dx.doi.org/10.1096/fj.08-112110.
39. World Health Organization. 2014. Confirmed human cases of avian influenza A(H7N9) reported to WHO. Report 18: data in WHO/HQ as of 14 July 2014. World Health Organization, Geneva, Switzerland. http://www.who.int/influenza/human_animal_interface/influenza_h7n9/18_reportwebh7n9number_20140714.pdf?ua=1.
40. World Health Organization. 27 July 2014. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2014. World Health Organization, Geneva, Switzerland. http://www.who.int/influenza/human_animal_interface/EN_GIP_20140727CumulativeNumberH5N1cases.pdf?ua=1.
41. Ramos I, Krammer F, Hai R, Aguilera D, Bernal-Rubio D, Steel J, Garcia-Sastre A, Fernandez-Sesma A. 2013. H7N9 influenza viruses interact preferentially with α2,3-linked sialic acids and bind weakly to α2,6-linked sialic acids. J Gen Virol 94:2417-2423. http://dx.doi.org/10.1099/vir.0.056184-0.
42. Xiong X, Martin SR, Haire LF, Wharton SA, Daniels RS, Bennett MS, McCauley JW, Collins PJ, Walker PA, Skehel JJ, Gamblin SJ. 2013. Receptor binding by an H7N9 influenza virus from humans. Nature 499: 496-499. http://dx.doi.org/10.1038/nature12372.
43. van Riel D, Leijten LM, de Graaf M, Siegers JY, Short KR, Spronken MI, Schrauwen EJ, Fouchier RA, Osterhaus AD, Kuiken T. 2013. Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans. Am J Pathol 183:1137-1143. http://dx.doi.org/10.1016/j.ajpath.2013.06.011.
44. Hudjetz B, Gabriel G. 2012. Human-like PB2 627K influenza virus polymerase activity is regulated by importin-α1 and-α7. PLoS Pathog 8:e1002488. http://dx.doi.org/10.1371/journal.ppat.1002488.
45. Subbarao EK, London W, Murphy BR. 1993. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67:1761-1764.
46. Moltedo B, Lopez CB, Pazos M, Becker MI, Hermesh T, Moran TM. 2009. Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 183:3569-3573. http://dx.doi.org/10.4049/jimmunol.0900091.
47. Torreira E, Schoehn G, Fernandez Y, Jorba N, Ruigrok RW, Cusack S, Ortin J, Llorca O. 2007. Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer. Nucleic Acids Res 35:3774-3783. http://dx.doi.org/10.1093/nar/gkm336.
48. Ye Q, Krug RM, Tao YJ. 2006. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444:1078-1082. http://dx.doi.org/10.1038/nature05379.
49. Arranz R, Coloma R, Chichon FJ, Conesa JJ, Carrascosa JL, Valpuesta JM, Ortin J, Martin-Benito J. 2012. The structure of native influenza virion ribonucleoproteins. Science 338:1634-1637. http://dx.doi.org/10.1126/science.1228172.
50. Turan K, Mibayashi M, Sugiyama K, Saito S, Numajiri A, Nagata K. 2004. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res 32:643-652. http://dx.doi.org/10.1093/nar/gkh192.
51. Verhelst J, Parthoens E, Schepens B, Fiers W, Saelens X. 2012. Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. J Virol 86:13445-13455. http://dx.doi.org/10.1128/JVI.01682-12.
52. Chen H, Yuan H, Gao R, Zhang J, Wang D, Xiong Y, Fan G, Yang F, Li X, Zhou J, Zou S, Yang L, Chen T, Dong L, Bo H, Zhao X, Zhang Y, Lan Y, Bai T, Dong J, Li Q, Wang S, Zhang Y, Li H, Gong T, Shi Y, Ni X, Li J, Zhou J, Fan J, Wu J, Zhou X, Hu M, Wan J, Yang W, Li D, Wu G, Feng Z, Gao GF, Wang Y, Jin Q, Liu M, Shu Y. 2014. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 383:714-721. http://dx.doi.org/10.1016/S0140-6736(14)60111-2.
53. Guan Y, Shortridge KF, Krauss S, Webster RG. 1999. Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci USA 96:9363-9367. http://dx.doi.org/10.1073/pnas.96.16.9363.
54. Bazzigher L, Schwarz A, Staeheli P. 1993. No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein. Virology 195:100-112. http://dx.doi.org/10.1006/viro.1993.1350.
55. Bernasconi D, Schultz U, Staeheli P. 1995. The interferon-induced Mx protein of chickens lacks antiviral activity. J Interferon Cytokine Res 15: 47-53. http://dx.doi.org/10.1089/jir.1995.15.47.
56. Wu R, Sui Z, Liu Z, Liang W, Yang K, Xiong Z, Xu D. 2010. Transmission of avian H9N2 influenza viruses in a murine model. Vet Microbiol 142:211-216. http://dx.doi.org/10.1016/j.vetmic.2009.09.068.
57. Wu R, Zhang H, Yang K, Liang W, Xiong Z, Liu Z, Yang X, Shao H, Zheng X, Chen M, Xu D. 2009. Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice. Vet Microbiol 138:85-91. http://dx.doi.org/10.1016/j.vetmic.2009.03.010.
58. Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z. 2006. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin-or neuraminidaseexpressing DNA in BALB/c mice. Biochem Biophys Res Commun 343: 1124-1131. http://dx.doi.org/10.1016/j.bbrc.2006.03.088.
59. -ΔΔCT method. Methods 25: 402-408. http://dx.doi.org/10.1006/meth.2001.1262.